Atazanavir CAS 198904-31-3 Puritas ≥99.0% API Factory Anti-HIV HIV-1 Protease Inhibitor

Description:

Chemical Name: Atazanavir

CAS: 198904-31-3

Aspectus: pulveris albi

Puritas: ≥99.0%

HIV-1 Protease Inhibitor

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Copia cum summa puritate et stabulo Quality
Chemical Name: Atazanavir
CAS: 198904-31-3
HIV-1 Protease Inhibitor
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Atazanavir
Synonyma	BMS-232632
CAS Number	198904-31-3
CATTUS Number	RF-API70
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C38H52N6O7
M. Pondus	704.86
Liquescens punctum	207.0~209.0℃
Solubilitas	Solutum in DMSO;Insolubilis in aqua
Long-Term PRAECLUSIO	Copia Diu terminus in -20℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba pulveris
Forma	Free Base
Damnum in Siccatio	≤0.50%
Residere in Ignition	≤0.20%
Metalla gravis	≤20ppm
immunditiam A	≤0.10%
impudicitia B	≤0.10%
una immunditia	≤0.20%
Totalis immunditias	≤1.0%
Puritas / Analysis Methodo	≥99.0% (HPLC)
pH	5.0~8.0
Test Standard	Enterprise Standard
Consuetudinem	HIV-1 Protease Inhibitor Anti-HIV

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Atazanavir (CAS 198904-31-3) est antiretrovirale, novum et potentissimum medicamentum azapeptidis inhibitoris protease (PI) classis.Venundatur sub commercio nomine Reyataz.Sicut aliae antiretrovirales, tractant contagionem immuno- tiae viri generis 1 (HIV-1) protease enzyme cum inhibitione constanti Ki of 66 nmol/L et etiam vetat replicationem viralem HIV-1 cum 50% retrahitur efficax EC50 vndique ab 2.6 ad 5.3 nmol/L.Atazanavir obligat ad HIV-1 protease impediendam fissuram gag et gag-pol polyproteinorum, quae consequitur formationem virionum immaturarum in cellulis HIV-1-infectis.Atazanavir structuram chemicam symmetricam C-2 diversam et plerumque maiorem antiretroviralem potentiam in variis HIV modis comparatam cum aliis inhibitoribus protease, inter Indinavir, Nelfinavir, Ritonavir, Saquinavir et Amprenavir.Atazanavir ab aliis Pis distinguitur in eo quod semel in die tribui potest et effectus minores in profile lipidorum patientis habet.Sicut alii protease inhibitores, solum in medicamentis aliis HIV coniunctim adhibetur.Atazanavir nova azapeptide HIV protease inhibitor est.Antiviral.Capitur semel in die ore.